Inappropriate Prescribing of Proton-pump Inhibitor is it Associated With the Burden of Comorbidities in Older Patients?
IPP SA
1 other identifier
observational
280
1 country
1
Brief Summary
Proton pump inhibitors (PPIs) are one of the most frequently prescribed classes of drugs in the world and the most effective drugs available to reduce gastric acid secretion. However, studies have shown that PPIs are not always prescribed with a clear indication. Indeed, between 25% and 86% of older individuals taking a PPI have been overprescribed these medications. In older patients, overprescribing of a PPI is associated with increases in morbidity, adverse drug events, hospitalization, and mortality. The hypothesis is that overprescription of PPIs is associated with the individual multimorbidities in older patients evaluated using the multimorbidities group criteria included in the CIRS. The aim of the present study was to establish a relationship between overprescribing of PPIs and multimorbidities in older patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 20, 2016
CompletedFirst Posted
Study publicly available on registry
July 22, 2016
CompletedJuly 26, 2016
July 1, 2016
6 months
July 20, 2016
July 25, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Burden of comorbidities
Burden of comorbidities is assessed by the CIRS (Cumulative Illness Rating Scale)
48 hours after the entry into acute geriatric medicine
Eligibility Criteria
Older patients aged 75 and over hospitalized in acute geriatric medicine
You may qualify if:
- Patients of 75 years or more
- Patients hospitalized in geriatric short stay
- Patients with an inhibitor therapy proton pump short geriatric entry
- Patients who have given their written consent
You may not qualify if:
- Patients who have expressed their inability or refusal to sign an informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de St Nazaire
Saint-Nazaire, 44606, France
Study Officials
- PRINCIPAL INVESTIGATOR
Laure De DECKER, Dr
Nantes University Hospital
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2016
First Posted
July 22, 2016
Study Start
January 1, 2014
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
July 26, 2016
Record last verified: 2016-07